A*Star改组, 重心倾向生物医学领域
猫兄或成一大赢家 A*Star to undergo major restructuring
This will help agency keep up with biomed industry and meet CFE objectives, says DPM Teo
A*STAR - the lead public sector agency that spearheads Singapore's research and development (R&D) work - will soon undergo a major restructuring.
Deputy Prime Minister Teo Chee Hean, who broke the news to the media on Monday, said that the restructuring will enable A*Star to keep up with a biomedical industry that has "transformed tremendously", and meet the objectives of the Committee on the Future Economy (CFE), which were unveiled just last week.
The minister was speaking to reporters on Monday at the sidelines of his visit to A*Star's Experimental Therapeutics Centre, which was set up to advance small-molecule drug discovery in Singapore. ETC will celebrate its 10th anniversary in March.
DPM Teo added that A*Star will be building a "similar centre for large molecules", which will be known as the Experimental Biologics Centre (EBC). No timeframe was disclosed.
来源: http://www.businesstimes.com.sg/government-economy/singapores-future-economy/astar-to-undergo-major-restructuring